<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Intralesional Vitamin D3 &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/intralesional-vitamin-d3/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 17 Jan 2026 18:48:37 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Intralesional Vitamin D3 &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Vitamin D3 vs. Glycolic Acid in Acanthosis Treatment</title>
		<link>https://bioengineer.org/vitamin-d3-vs-glycolic-acid-in-acanthosis-treatment/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 17 Jan 2026 18:48:37 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Dermatology Research]]></category>
		<category><![CDATA[Glycolic Acid Peeling]]></category>
		<category><![CDATA[Intralesional Vitamin D3]]></category>
		<category><![CDATA[İşte bu içerik için uygun 5 etiket: **Pseudo-acanthosis Nigricans]]></category>
		<category><![CDATA[Randomized Clinical Trial** **Açıklama:** 1. **Pseudo-acanthosis Nigricans:** Yazının doğrudan konusu olan dermatolojik durum. 2. **Intralesional Vitamin D3:** Ara]]></category>
		<guid isPermaLink="false">https://bioengineer.org/vitamin-d3-vs-glycolic-acid-in-acanthosis-treatment/</guid>

					<description><![CDATA[In a groundbreaking study set to be published in 2026, researchers have explored the efficacy of intralesional vitamin D3 as a treatment modality for pseudo-acanthosis nigricans, an often-overlooked dermatological condition characterized by dark, velvety patches on the skin. This randomized comparative study, conducted by a team of experts including Moftah, Hamdino, and Mansour, compares the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">317806</post-id>	</item>
	</channel>
</rss>
